Download Files:
BRD7-IN-2
SKU
HY-149420-Get quote
Category Reference compound
Tags Epigenetic Reader Domain, Epigenetics, Others
Products Details
Product Description
– BRD7-IN-2 (compound 2-77) is a potent inhibitor of bromodomain-containing protein 7 (BRD7), targeting to prostate cancer cells. BRD7-IN-2 is selective for BRD7 rather than BRD9, with IC50s of 5.4 μM, and >300 μM, respectively.
Web ID
– HY-149420
Shipping
– Room temperature
Molecular Formula
– C18H18N2O3
References
– [1]Ordonez-Rubiano SC, Maschinot CA, Wang S, Sood S, Baracaldo-Lancheros LF, Strohmier BP, McQuade AJ, Smith BC, Dykhuizen EC. Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer. J Med Chem. 2023 Aug 24;66(16):11250-11270.
Molecular Weight
– 310.35
SMILES
– CN1C2=C(C=CC(C3=CC=C(OC)N=C3OC)=C2)C(C)=CC1=O
Clinical Information
– No Development Reported
Research Area
– others
Solubility
– 10 mM in DMSO
Target
– Epigenetic Reader Domain
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.